Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goetz

Showing results (381-390 of 397) with videos related to

Pageof 40
Sort By:
The New England Journal of Medicine|June 5, 2018
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)E L Mayer, D Hlauschek, M Gnant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 17, 2024
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 18, 2021
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023William J Gradishar, Meena S Moran, Jame Abraham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancerP A Francis, O Pagani, G F Fleming, et al.
ESMO Open|June 5, 2025
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)M J Naughton, D M Zahrieh, M Gnant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
NPJ Breast Cancer|February 13, 2025
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancerRita A Mukhtar, Soumya Gottipati, Christina Yau, et al.
Pageof 40

Showing results (381-390 of 397) with videos related to

Sort By:
Pageof 40
The New England Journal of Medicine|June 5, 2018
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)E L Mayer, D Hlauschek, M Gnant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 17, 2024
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 18, 2021
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023William J Gradishar, Meena S Moran, Jame Abraham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancerP A Francis, O Pagani, G F Fleming, et al.
ESMO Open|June 5, 2025
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)M J Naughton, D M Zahrieh, M Gnant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
NPJ Breast Cancer|February 13, 2025
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancerRita A Mukhtar, Soumya Gottipati, Christina Yau, et al.
Pageof 40